Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-078150
Filing Date
2022-07-07
Accepted
2022-07-07 19:29:49
Documents
2
Period of Report
2022-07-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2219512-12_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2219512-12_3seq1.xml 3 4341
2 EXHIBIT 24 tm2219512d12_ex24.htm EX-24 13513
  Complete submission text file 0001104659-22-078150.txt   19339
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Issuer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROTROPE, INC. 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102
Business Address
ALTSTIEL LARRY DOUGLAS (Reporting) CIK: 0001619444 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41429 | Film No.: 221072595